约 1,160 个结果
在新选项卡中打开链接
AUGTYRO™ (repotrectinib) - New FDA Approved ROS1+ Non …
AUGTYRO (repotrectinib) is an oral prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) that: Has spread within your chest or to other parts of the body AND Is …
Starting ROS1+ Lung Cancer Treatment - AUGTYRO
AUGTYRO (repotrectinib) is an oral prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) that: Has spread within your chest or to other parts of the body AND Is …
NTRK+ Targeted Treatment | AUGTYRO™ (repotrectinib)
Find information on how to get started with AUGTYRO™ (repotrectinib) to help treat NTRK+ cancers. Learn about efficacy, patient support, cost and access, and more.
AUGTYRO™ (repotrectinib) - New FDA Approved ROS1+ Non …
AUGTYRO™ (repotrectinib) - New FDA Approved ROS1+ Non-Small Cell Lung ...